Published in Curr Treat Options Cardiovasc Med on June 01, 2007
Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1. J Neurosci (2008) 1.33
Neurorestorative therapy for stroke. Front Hum Neurosci (2014) 1.13
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med (2009) 1.01
Repairing neural injuries using human umbilical cord blood. Mol Neurobiol (2012) 0.87
Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Res (2012) 0.84
Angiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal Medicine. J Clin Med (2016) 0.81
Abluminal stimulation of sphingosine 1-phosphate receptors 1 and 3 promotes and stabilizes endothelial sprout formation. Tissue Eng Part A (2014) 0.75
Time course of neuroprotection induced by in vivo normobaric hyperoxia preconditioning and angiogenesis factors. Iran J Basic Med Sci (2017) 0.75
Mural lymphatic endothelial cells regulate meningeal angiogenesis in the zebrafish. Nat Neurosci (2017) 0.75
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents. J Stroke (2017) 0.75
Human neural stem cell therapy for chronic ischemic stroke: charting progress from laboratory to patients. Stem Cells Dev (2017) 0.75
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med (2008) 28.42
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med (2015) 6.96
Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet (2008) 4.14
Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke (2004) 3.60
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke (2003) 3.18
Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke (2010) 2.78
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet (2012) 2.69
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol (2009) 2.64
[Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)]. Rev Neurol (2011) 2.57
The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke (2008) 1.77
The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke (2007) 1.73
Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke (2004) 1.73
Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels. Clin Sci (Lond) (2011) 1.73
The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke (2005) 1.58
The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men. Stroke (2008) 1.47
Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke (2003) 1.45
Comparison of preperfusion and postperfusion magnetic resonance angiography in acute stroke. Stroke (2004) 1.44
[Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia]. Med Clin (Barc) (2003) 1.41
Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke (2004) 1.41
Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis. Stroke (2013) 1.40
[Statins and stroke]. Med Clin (Barc) (2008) 1.39
Usefulness of material recovered from distal embolic protection devices after carotid angioplasty for proteomic studies. J Vasc Interv Radiol (2012) 1.39
Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke (2002) 1.36
Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab (2011) 1.31
Stroke on awakening: looking for a more rational management. Cerebrovasc Dis (2003) 1.30
Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg (2003) 1.27
Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J Cereb Blood Flow Metab (2011) 1.25
Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke (2002) 1.24
Role of inflammatory markers in brain ischemia. Curr Opin Neurol (2008) 1.22
Inflammation as therapeutic objective in stroke. Curr Pharm Des (2008) 1.17
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab (2006) 1.17
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias. Cerebellum (2010) 1.16
Iron-related brain damage in patients with intracerebral hemorrhage. Stroke (2010) 1.13
A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med (2006) 1.12
Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: the TICA study. Hypertension (2009) 1.11
A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett (2002) 1.11
Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc Dis (2009) 1.11
TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab (2005) 1.08
High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke. J Cereb Blood Flow Metab (2011) 1.08
Targeting the ischemic penumbra. Stroke (2010) 1.07
Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 1.07
Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale. Stroke (2013) 1.06
The metabolic syndrome and stroke: potential treatment approaches. Stroke (2007) 1.05
A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke (2010) 1.04
Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis (2005) 1.03
Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med (2009) 1.01
Proteomic analysis of the tear film in patients with keratoconus. Mol Vis (2010) 1.00
Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Neurology (2012) 0.96
Ischemic preconditioning: a novel target for neuroprotective therapy. Cerebrovasc Dis (2006) 0.96
Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype. Stroke (2009) 0.96
Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model. Stroke (2013) 0.96
Structural brain changes and cognition in relation to markers of vascular dysfunction. Neurobiol Aging (2011) 0.95
High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA. Stroke (2008) 0.95
Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis (2006) 0.95
Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke (2005) 0.94
Oxaloacetate: a novel neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol (2011) 0.94
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. Stroke (2006) 0.94
Glutamate excitoxicity is the key molecular mechanism which is influenced by body temperature during the acute phase of brain stroke. PLoS One (2012) 0.94
Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy. Stroke (2014) 0.93
Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin Immunol (2011) 0.93
Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke. J Neurosci Res (2012) 0.93
Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia. Int J Pharm (2010) 0.91
IMS-III and SYNTHESIS Expansion trials of endovascular therapy in acute ischemic stroke: how can we improve? Stroke (2013) 0.91
Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke. Stroke (2011) 0.90